Werewolf Therapeutics(HOWL)
$0.980.00 (0.00%)
HOWL
Werewolf Therapeutics financials statements
$0.98
At close:0.00 (0.00%)
Want to see HOWL full AI Analyst Report?
Werewolf Therapeutics (HOWL) Income Statement
805 Followers
Werewolf Therapeutics Income Statement
Last quarter (Q2 2026), Werewolf Therapeutics's total revenue was $21.00M. In Q2, Werewolf Therapeutics's net income was $3.67M. See Werewolf Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 1.89M | $ 19.94M | $ 16.40M | $ 0.00 | |
| $ -1.63M | $ 71.00K | $ 18.18M | $ 13.89M | $ 0.00 | |
| $ 59.04M | $ 73.67M | $ 58.68M | $ 69.95M | $ 50.09M | |
| Depreciation and Amortization | $ 1.63M | $ 1.81M | $ 1.76M | $ 1.10M | $ 216.00K |
| $ -53.91M | $ -64.05M | $ -32.47M | $ -52.71M | $ -49.77M | |
| $ -60.68M | $ -73.59M | $ -40.50M | $ -56.06M | $ -50.09M | |
| $ -145.00K | $ 3.08M | $ 3.13M | $ 2.25M | $ 104.00K | |
| $ -60.82M | $ -70.52M | $ -37.37M | $ -53.81M | $ -49.98M | |
| $ -60.82M | $ -70.52M | $ -37.37M | $ -53.81M | $ -49.98M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.32 | $ -1.63 | $ -1.05 | $ -1.86 | $ -10.94 |
| Diluted EPS | $ -1.33 | $ -1.63 | $ -1.05 | $ -1.86 | $ -10.94 |
| Weighted Average Shares Outstanding | 46.02M | 43.33M | 35.65M | 28.86M | 18.45M |
| Weighted Average Shares Outstanding (Diluted) | 46.81M | 43.86M | 35.65M | 28.86M | 18.45M |
Currency in USD
